Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03576274 · ClinicalTrials.gov registry record · NA
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
A NA study of Exercise and Cancer-related Problem/Condition, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT03576274: Completed NA study of Exercise and Cancer-related Problem/Condition, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
NCT03576274 is a NA study of Exercise and Cancer-related Problem/Condition that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 110 participants, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03576274, a NA study of Exercise and Cancer-related Problem/Condition, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
A 12 weeks technology enhanced home exercise (TEHE) program using mobile technologies that provide immediate feedback and send reminder messages to improve exercise motivation is developed. Investigators combine this TEHE program with techniques including auricular point pressure (APA) and brief mindfulness body scan (MBI). This study will examine the feasibility of the TEHE program and combined programs, and ascertain the effect of TEHE program alone, the combined programs on fatigue and biological markers among cancer survivors. Main Research Variable(s): The independent variables are the 12-week program of TEHE alone, APA alone, combined APA and TEHE (TEHEplus) and combined MBI and TEHE (TEHE-MBI). Outcome variables are fatigue, physical activity, contributing factors of fatigue and biomarkers. Design: Repeated measures randomized controlled trial. Setting: Participants will be recruited through the Comprehensive Cancer Center, Johns Hopkins University. Sample: Participants diagnosed with non-metastatic solid tumor cancer; who had completed all primary cancer treatment (surgery, chemotherapy, and radiation therapy )within at least 3 months OR non-metastatic prostate cancer completed all primary cancer treatment and have hormone therapy for at least 6 month, OR participants diagnosed with solid tumor cancer; who are receiving immunotherapy for at least 3 months before enrollment, aged 21 years or older, experiencing fatigue in the past 7 days on average of ≥ 3/10, able to participate in a moderate-intensity exercise training program, self-report ability to complete the 6 min walk test with a perceived exertion of 3 or below, and can communicate in English. Methods: Participants who meet the inclusion criteria will be randomly assigned to the TEHE only, APA only or TEHEplus or TEHE-MBI or control group. All exercise groups (TEHE) will be offered a 12-week exercise program through an online communication. In additional to the TEHE, the TEHEplus group will receiv
Primary Outcome
Fatigue will be measured by the self-report questionnaire including 1) the PROMIS-F, self self-report measure that assesses fatigue over the past 7 days. Score range 8-40 with higher score indicating worse fatigue.
Conditions Studied
Interventions
- BEHAVIORAL Technology Enhanced Home Exercise (TEHE)
- BEHAVIORAL Auricular Point Acupressure (APA)
- BEHAVIORAL Mindfulness body scan (MBI)
Study Locations (1)
Maryland
- The Sidney Kimmel Comprehensive Cancer Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-10-10 |
| Est. Completion | 2024-09-15 |
| Phase | NA |
What the finished NCT03576274 record still lists
NCT03576274 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 8,909-participant average among 57 other Exercise trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Exercise appearing as the primary indexed condition, and to 3 interventions - of which Technology Enhanced Home Exercise (TEHE) is the first listed.
NCT03576274 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03576274 about?
NCT03576274 is a clinical study titled "Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors". A 12 weeks technology enhanced home exercise (TEHE) program using mobile technologies that provide immediate feedback and send reminder messages to improve exercise motivation is developed. Investigators combine this TEHE program with techniques including auricular point pressure (APA) and brief min...
What is the current status of trial NCT03576274?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2019-10-10. Estimated completion is 2024-09-15.
What conditions does trial NCT03576274 study?
This clinical trial studies the following conditions: Exercise, Cancer-related Problem/Condition, Acupressure.
What interventions are being tested in trial NCT03576274?
The interventions under investigation include: Technology Enhanced Home Exercise (TEHE) (BEHAVIORAL), Auricular Point Acupressure (APA) (BEHAVIORAL), Mindfulness body scan (MBI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03576274?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03576274 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exercise
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03576274's enrollment target sits among peer trials
110 21st of 57 higher than 37 of 57 other Exercise trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
RECRUITING · NA
-
Better Lifestyle Counseling for African American Women During Pregnancy
RECRUITING · NA
-
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI